Literature DB >> 141993

Interpretation of the serum digoxin concentration.

M Weintraub.   

Abstract

Significant problems exist in the interpretation of serum digoxin concentration data. Failure to distinguish between results that do not require precise clinical correlation (proof of absorption, presence of drug, etc) and those which depend upon clinical correlation for their meaning ('toxicity' or 'effectiveness') can result in interpretive errors. Problems relating to the source of the serum digoxin concentration can also confound interpretation. Such difficulty may be controllable (obtaining the sample at the proper time, haemolysis, etc) or related to the laboratory technique (cross-reactivity with digoxin metabolites or other medications, technical errors, or lack of precision). Variation within the same patient over time or between patients related to disease (alterations in electrolytes, adrenergic or parasympathomimetic tone, or other medications) may prevent the direct attribution of an observed phenomenon to a particular digoxin concentration. Techniques for determining the effect of digoxin do exist and can be used to gather data for clinical correlations. Ways of improving the interpretaion of serum digoxin concentrations also exist and should be used to improve their value in patient management. The serum digoxin concentration seems to have an important future role. However, we need to know how better to interpret and exploit serum digoxin concentration data.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 141993     DOI: 10.2165/00003088-197702030-00005

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  53 in total

1.  Correlation of serum concentrations with heart concentrations of digoxin in human subjects.

Authors:  H G Güllner; E B Stinson; D C Harrison; S M Kalman
Journal:  Circulation       Date:  1974-10       Impact factor: 29.690

2.  Effect of propantheline and metoclopramide on absorption of digoxin.

Authors:  V Manninen; A Apajalahti; H Simonen; P Reissell
Journal:  Lancet       Date:  1973-05-19       Impact factor: 79.321

3.  The absorption of orally administered (12 - 3 H)digoxin in man.

Authors:  B Beermann; K Hellström; A Rosén
Journal:  Clin Sci       Date:  1972-10       Impact factor: 6.124

4.  Atrioventricular block due to accidental digoxin ingestion treated with atropine.

Authors:  M Duke
Journal:  Am J Dis Child       Date:  1972-11

5.  Digoxin metabolism in obesity.

Authors:  G A Ewy; B M Groves; M F Ball; L Nimmo; B Jackson; F Marcus
Journal:  Circulation       Date:  1971-11       Impact factor: 29.690

6.  Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay.

Authors:  T W Smith; V P Butler; E Haber
Journal:  N Engl J Med       Date:  1969-11-27       Impact factor: 91.245

7.  Insensitivity to digoxin associated with hypocalcemia.

Authors:  D Chopra; P Janson; C T Sawin
Journal:  N Engl J Med       Date:  1977-04-21       Impact factor: 91.245

8.  Human serum and myocardium digoxin.

Authors:  G Härtel; K Kyllönen; E Merikallio; K Ojala; V Manninen; P Reissell
Journal:  Clin Pharmacol Ther       Date:  1976-02       Impact factor: 6.875

9.  Inhibition of digoxin absorption by neomycin.

Authors:  J Lindenbaum; R M Maulitz; V P Butler
Journal:  Gastroenterology       Date:  1976-09       Impact factor: 22.682

10.  Dose-response relation between therapeutic levels of serum digoxin and systolic time intervals.

Authors:  R J Hoeschen; T E Cuddy
Journal:  Am J Cardiol       Date:  1975-04       Impact factor: 2.778

View more
  6 in total

Review 1.  Therapeutic drug monitoring in saliva.

Authors:  M Danhof; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

2.  Prediction of digoxin dose requirements.

Authors:  S M Dobbs; G E Mawer
Journal:  Clin Pharmacokinet       Date:  1977 Jul-Aug       Impact factor: 6.447

Review 3.  Clinical relevance of pharmacokinetics.

Authors:  G Tognoni; C Bellantuono; M Bonati; M D'Incalci; M Gerna; R Latini; M Mandelli; M G Porro; E Riva
Journal:  Clin Pharmacokinet       Date:  1980 Mar-Apr       Impact factor: 6.447

Review 4.  Interpretation of drug levels in acute and chronic disease states.

Authors:  E Perucca; R Grimaldi; A Crema
Journal:  Clin Pharmacokinet       Date:  1985 Nov-Dec       Impact factor: 6.447

5.  Digoxin dosage in renal insufficiency: impracticality of basing it on the creatinine clearance, body weight and volume of distribution.

Authors:  F Keller; M Molzahn; R Ingerowski
Journal:  Eur J Clin Pharmacol       Date:  1980-11       Impact factor: 2.953

Review 6.  Comparison of drug dosing methods.

Authors:  M E Burton; M R Vasko; D C Brater
Journal:  Clin Pharmacokinet       Date:  1985 Jan-Feb       Impact factor: 6.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.